Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika
About Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Genentech, Inc.
2
Institut de Recherches Internationales Servier
2
BioNTech SE
1
Celldex Therapeutics
1
ERYtech Pharma
1
Genmab
1
Heidelberg Pharma AG
1
Helsinn Healthcare SA
1
Onxeo
1
Sanofi
1
Clinical Trials at Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika
During the past decade, Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on
average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
2000-12-01
2008-10-01
Completed
Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer
2005-12-01
2008-04-01
Terminated
165
Gemcitabine With or Without WX-671 in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
2007-04-01
2010-05-01
Completed
95
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
2008-10-16
2029-09-20
Recruiting
720
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
2011-11-01
2016-11-01
Completed
745
Efficacy and Safety Doxorubicin Transdrug Study in Patients Suffering From Advanced Hepatocellular Carcinoma
2012-06-01
2019-05-01
Completed
397
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer
2013-06-10
2019-12-31
Completed
780
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Genentech, Inc." with 2 trials
sponsored, "Institut de Recherches Internationales Servier" with 2 trials sponsored, "BioNTech SE" with 1 trials sponsored and "Celldex Therapeutics"
with 1 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika"
#1 collaborator was "Breast International Group" with 3 trials as a collaborator, "ADIR, a Servier Group company" with 1 trials as a collaborator, "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "BioNTech SE" with 1 trials as a collaborator and "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika
According to Clinical.Site data, the most researched conditions in "Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika" are
"Breast Cancer" (4 trials), "Triple Negative Breast Cancer" (2 trials), "Carcinoma, Hepatocellular" (1 trials), "Carcinoma, Squamous Cell" (1 trials) and "Carcinoma, Squamous Cell of Head and Neck" (1 trials). Many other conditions were trialed in "Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika" in a lesser frequency.
Clinical Trials Intervention Types at Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika
Most popular intervention types in "Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika" are "Drug" (16 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Pertuzumab" (4 trials), "Placebo" (4 trials), "Trastuzumab" (4 trials), "5-Fluorouracil" (3 trials) and "Docetaxel" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika
The vast majority of trials in "Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika" are
14 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika
Currently, there are NaN active trials in "Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika, 2 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".